Toxicity risks evaluation of unknown FDA biotransformed drugs based on a multi-objective feature selection approach - researchr publication authors

researchr

You are not signed in
Sign in
Sign up

Mohamed Abd El-Aziz 0001, Yasmine S. Moemen, Aboul Ella Hassanien, Shengwu Xiong. Toxicity risks evaluation of unknown FDA biotransformed drugs based on a multi-objective feature selection approach. Appl. Soft Comput., 97(Part):105509, 2020. [doi]

This author has not been identified. Look up 'Mohamed Abd El-Aziz 0001' in GoogleThis author has not been identified. Look up 'Yasmine S. Moemen' in GoogleThis author has not been identified. Look up 'Aboul Ella Hassanien' in GoogleThis author has not been identified. Look up 'Shengwu Xiong' in Google

runs on WebDSL